Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Modzelewski

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2010
Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot studyPierre Vera, Pierre Bohn, Agathe Edet-Sanson, et al.
Leukemia & Lymphoma|June 21, 2013
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyHélène Lanic, Jerôme Kraut-Tauzia, Romain Modzelewski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2016
Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell LymphomaAnne-Ségolène Cottereau, Sebastien Hapdey, Loic Chartier, et al.
Radiation Oncology (London, England)|October 25, 2018
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancerSébastien Thureau, Bernard Dubray, Romain Modzelewski, et al.
Cancers|March 29, 2023
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx CancersPierrick Gouel, Françoise Callonnec, Franchel-Raïs Obongo-Anga, et al.
Radiation Oncology (London, England)|May 24, 2020
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancerRomain Mallet, Romain Modzelewski, Justine Lequesne, et al.
Journal of Computer Assisted Tomography|July 31, 2008
Development and validation of the random walk algorithm: application to the classification of diffuse heterogeneity in brain SPECT perfusion imagesRomain Modzelewski, Thierry de la Rue, Elise Janvresse, et al.
Frontiers in Oncology|February 14, 2025
Early characterization and prediction of glioblastoma and brain metastasis treatment efficacy using medical imaging-based radiomics and artificial intelligence algorithmsNoémie N Moreau, Samuel Valable, Cyril Jaudet, et al.
Entropy (Basel, Switzerland)|April 23, 2022
A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome PredictionThibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
Entropy (Basel, Switzerland)|May 28, 2022
Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome Prediction. <i>Entropy</i> 2022, <i>24</i>, 436Thibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2010
Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot studyPierre Vera, Pierre Bohn, Agathe Edet-Sanson, et al.
Leukemia & Lymphoma|June 21, 2013
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyHélène Lanic, Jerôme Kraut-Tauzia, Romain Modzelewski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2016
Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell LymphomaAnne-Ségolène Cottereau, Sebastien Hapdey, Loic Chartier, et al.
Radiation Oncology (London, England)|October 25, 2018
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancerSébastien Thureau, Bernard Dubray, Romain Modzelewski, et al.
Cancers|March 29, 2023
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx CancersPierrick Gouel, Françoise Callonnec, Franchel-Raïs Obongo-Anga, et al.
Radiation Oncology (London, England)|May 24, 2020
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancerRomain Mallet, Romain Modzelewski, Justine Lequesne, et al.
Journal of Computer Assisted Tomography|July 31, 2008
Development and validation of the random walk algorithm: application to the classification of diffuse heterogeneity in brain SPECT perfusion imagesRomain Modzelewski, Thierry de la Rue, Elise Janvresse, et al.
Frontiers in Oncology|February 14, 2025
Early characterization and prediction of glioblastoma and brain metastasis treatment efficacy using medical imaging-based radiomics and artificial intelligence algorithmsNoémie N Moreau, Samuel Valable, Cyril Jaudet, et al.
Entropy (Basel, Switzerland)|April 23, 2022
A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome PredictionThibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
Entropy (Basel, Switzerland)|May 28, 2022
Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome Prediction. <i>Entropy</i> 2022, <i>24</i>, 436Thibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
Pageof 6